Bryant A. Toth, MD, FACS
San Francisco, California, 94115, United States
NCT Number: NCT00662389
The purpose of this feasibility study is to gain an initial assessment of the acute safety and performance of the Apsara Thermal Wand System in human facial tissue.
Looking for future studies?
Notify Me40 year–65 year
All sexes
Interventional
Early Phase 1
San Francisco, California, 94115, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single radiofrequency cycle to dermal tissue
Time frame: Immediate
Number of Serious Adverse Events
Apsara Medical Corporation
Industry
TP-1013 Pilot 1: Application of the Apsara Thermal Wand System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04235803
Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Francisco, California, United States
View Trial DetailsNCT06724510
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Beijing, China
View Trial DetailsNCT06351358
Body Weight, Body Weight Changes
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03573271
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Sacramento, California, United States
View Trial Details